Arax Advisory Partners’s Allegion ALLE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$604K Buy
4,302
+2,152
+100% +$292K ﹤0.01% 1517
2026
Q1
$312K Buy
2,150
+1,483
+222% +$237K 0.01% 864
2025
Q4
$106K Sell
667
-11,650
-95% -$1.94M ﹤0.01% 1311
2025
Q3
$2.18M Buy
12,317
+11,821
+2,383% +$1.95M 0.03% 439
2025
Q2
$71.5K Sell
496
-36
-7% -$4.92K ﹤0.01% 1085
2025
Q1
$69.4K Buy
532
+263
+98% +$34K ﹤0.01% 842
2024
Q4
$35.2K Sell
269
-52
-16% -$7.36K ﹤0.01% 1004
2024
Q3
$46.8K Buy
321
+12
+4% +$1.59K ﹤0.01% 745
2024
Q2
$36.5K Buy
309
+162
+110% +$20K ﹤0.01% 760
2024
Q1
$19.8K Hold
147
﹤0.01% 673
2023
Q4
$18.6K Hold
147
﹤0.01% 667
2023
Q3
$15.3K Hold
147
﹤0.01% 636
2023
Q2
$17.6K Hold
147
﹤0.01% 606
2023
Q1
$15.7K Sell
147
-23
-14% -$2.58K ﹤0.01% 622
2022
Q4
$17.9K Hold
170
﹤0.01% 576
2022
Q3
$15K Hold
170
﹤0.01% 606
2022
Q2
$17K Buy
+170
New +$18.4K ﹤0.01% 577

Other funds holding ALLE

Arax Advisory Partners's ALLE Position: Q2 2026 in Review

Arax Advisory Partners increased its Allegion (ALLE) stake by 100% in Q2 2026, buying an estimated $292K and bringing the position to 4,302 shares worth $604K. The position accounts for ﹤0.01% of the portfolio, ranked #1517.

Arax Advisory Partners first reported a position in ALLE in Q2 2022 and has held it in 17 quarters since. The position peaked at $2.18M in Q3 2025. 731 funds tracked by Wall St. Rank hold ALLE as of Q2 2026.

  • Arax Advisory Partners held 4,302 shares of Allegion worth $604K as of Q2 2026.
  • Arax Advisory Partners bought 2,152 Allegion shares in Q2 2026, an estimated $292K.
  • Allegion made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #1517 holding.
  • Arax Advisory Partners first reported a position in Allegion in Q2 2022 and has held it in 17 quarters since.
  • Arax Advisory Partners's Allegion position peaked at $2.18M in Q3 2025.
  • 731 funds tracked by Wall St. Rank held Allegion as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.